Effect of Olanzapine on Metabolic Syndrome- A One Year Follow-up Study

Effect of Olanzapine on Metabolic Syndrome- A One Year Follow-up Study

ABSTRACT Introduction: Patients with schizophrenia have increased risk of cardiovascular mortality and this is partly attributed to antipsychotics. Olanzapine, one of first line antipsychotic for the management of schizophrenia is associated with Metabolic syndrome (MetS). There is paucity of follo...

Full description

Bibliographic Details
Main Authors: KJ Samyukta, D Shivson, Suvarna Jyothi Kantipudi
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2020-06-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
cardiometabolic risk factors
psychosis
schizophrenia
second generation antipsychotic
Online Access:https://jcdr.net/articles/PDF/13773/44521_CE[Ra1]_F(SHU)_PF1(AG_SHU)_PFA(KM)_PB(AG_KM)_PN(SL).pdf

Similar Items

Similar Items